VIR vs MSFT: Which Stock is Better?
Side-by-side comparison of Vir Biotechnology Inc and Microsoft Corporation in 2026
VIR
Vir Biotechnology Inc
$11.64
MSFT
Microsoft Corporation
$498.41
Key Metrics Comparison
| Metric | VIR | MSFT | Winner |
|---|---|---|---|
| Market Cap | $1.45B | $3.71T | MSFT |
| P/E Ratio | N/A | 33.89 | VIR |
| EPS (TTM) | $N/A | $14.08 | MSFT |
| Revenue Growth | -13.9% | 18.4% | MSFT |
| Gross Margin | 0.0% | 67.9% | MSFT |
Analyze VIR
Full quant analysis
Analyze MSFT
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is VIR or MSFT a better investment?
Comparing VIR and MSFT: Vir Biotechnology Inc has a market cap of $1.45B while Microsoft Corporation has $3.71T. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between VIR and MSFT?
VIR (Vir Biotechnology Inc) and MSFT (Microsoft Corporation) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: VIR or MSFT?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: VIR or MSFT?
MSFT has higher revenue growth at 18.4% vs -13.9% for VIR.
Which company is more profitable: VIR or MSFT?
Microsoft Corporation (MSFT) has higher gross margins at 67.9% compared to 0.0% for VIR.
Which is the larger company: VIR or MSFT?
Microsoft Corporation (MSFT) is larger with a market cap of $3.71T compared to $1.45B for VIR.
Should I buy VIR or MSFT in 2026?
Both VIR and MSFT have investment merit. VIR trades at $11.64 while MSFT trades at $498.41. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between VIR and MSFT stock?
Key differences: Market Cap ($1.45B vs $3.71T), P/E Ratio (N/A vs 33.9x), Revenue Growth (-13.9% vs 18.4%), Gross Margin (0.0% vs 67.9%).
Should I buy VIR or MSFT in 2026?
The choice between VIR and MSFT depends on your investment goals. MSFT shows higher revenue growth (18.4%). MSFT has better margins (67.9%). Consider your risk tolerance and time horizon.
What is the market cap comparison between VIR and MSFT?
VIR (Vir Biotechnology Inc) has a market cap of $1.45B, while MSFT (Microsoft Corporation) has a market cap of $3.71T. MSFT is the larger company by market value.